Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 15/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356345 | 0.83 | ELANE (0.69) | ELANEPRTN3 | |
| SCHEMBL4888012 | 0.81 | ELANE (0.71) | ELANEPPARA | |
| SCHEMBL9328951 | 0.80 | ELANE (0.69) | ELANE | |
| SCHEMBL18566937 | 0.80 | ELANE (0.69) | ELANETHRBPPARA | |
| SCHEMBL10483720 | 0.79 | ELANE (1.00) | ELANEPRTN3 | |
| SCHEMBL22369614 | 0.78 | ELANE (0.86) | ELANEPRTN3 | |
| SCHEMBL19774318 | 0.78 | ELANE (0.61) | ELANETHRBPPARAMAPTSMN1; SMN2 | |
| SCHEMBL19670906 | 0.78 | ELANE (0.61) | ELANETHRBPPARAPPARG | |
| SCHEMBL4884952 | 0.78 | ELANE (0.56) | ELANETHRBPPARAPPARG | |
| SCHEMBL4881156 | 0.78 | ELANE (0.56) | ELANETHRBPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11124603-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11124603-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, MYB | ELANE 2832/4885THRB 3226/4885PPARA 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.